As BRAF inhibitor treatment also significantly enhanced BIM expression in BRAFV600E CRC cells (Fig. 1, Supplementary Fig. 2), we next assessed whether BIM was required for BRAF + BCL-XL inhibitor-induced apoptosis. Here, BCL2L1 is linked to colorectal carcinoma.